openPR Logo
Press release

Rise of Pregnancy in Older Women Will Have Societal Consequences, Warns Fertility Specialist

10-20-2011 09:11 AM CET | Health & Medicine

Press release from: Center for Human Reproduction

Rise of Pregnancy in Older Women Will Have Societal

October 19, 2011 (New York, NY) - The US has been trending toward higher rates of pregnancy in older women in the past several years, reports New York’s Center for Human Reproduction. Birth data for the United States indicates that birth rates have been increasing for women over 40, and this sector now represents the fastest growing group of women having children.

Different societal developments contribute to this development. More women are in the work force, there are fewer and later marriages, higher divorce rates and, of course, medical progress has allowed older women conceive into their 50s either with their own eggs or via egg donation.

Norbert Gleicher, MD and Medical Director of New York City’s Center for Human Reproduction (CHR) - a leading clinical and research center in infertility – has recently brought attention to the rising number of older women becoming mothers. In a blog published by CHR he notes that a number of media reports recently presented the pros and cons of pregnancy in older women. All reports, however, missed the most important conclusion to this seemingly sudden societal development (which in reality has been growing quietly for over a decade): the developed world is in the midst of a reproductive social revolution in which we will increasingly see older, and often single, women becoming mothers.

So far, the medical profession, academia and government have failed to address potential societal consequences of an increase in older mothers. The public and medical establishments are similarly skeptical and to a degree hostile to what some have derisively called “grandmothers having children.” Yet, Dr. Gleicher notes, “The trend [of pregnancy in older women] is irreversible, and can only be expected to accelerate.”

Dr. Gleicher further points out that at CHR the median patient age, which a decade ago was around 35 years, passed 40 in 2011. Egg donation, mostly utilized by older women who no longer have use of their own eggs, is CHR's most rapidly growing in vitro fertilization (IVF) program. Trends also can be seen nationally based on Center for Disease Control and Prevention data. Between 2004 and 2008 percentages of IVF cycles as a proportion of all IVF more than doubled above the age of 42. By 2008, egg donation cycles already represented 12.3% of all IVF cycles in the US.

“Medicine is not ready to manage pregnancy in older women safely and society is not ready to help them cope with older motherhood,” warns Dr. Gleicher. “Affected medical specialties have to develop the necessary expertise, whether they agree with patients’ decisions to be pregnant at advanced ages or not.” Feeling strongly about the subject, he concludes, “As we do not withhold care from smokers with lung cancer or from overly obese diabetics, it would be unethical to withhold care from older women desirous of motherhood.”

About CHR
Center for Human Reproduction (http://www.centerforhumanreprod.com) is a leading infertility center in New York City treating patients worldwide. CHR is well-recognized for its major clinical research program, which has contributed a number of essential breakthroughs to the IVF process. Dr. Gleicher is available for further comments.

Communications Manager
Center for Human Reproduction
21 E 69th St
New York NY USA 10021
212-994-4400
webadmin@thechr.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rise of Pregnancy in Older Women Will Have Societal Consequences, Warns Fertility Specialist here

News-ID: 196990 • Views:

More Releases from Center for Human Reproduction

IVF Success Rates Not Improved by Preimplantation Genetic Screening, According to CHR Research
IVF Success Rates Not Improved by Preimplantation Genetic Screening, According t …
There is no evidence that recent technical improvements in preimplantation genetic screening (PGS) improve IVF pregnancy chances, according to a paper just published online in the Journal of Assisted Reproduction and Genetics1. The review, by two fertility specialists from New York’s Center for Human Reproduction (CHR), raises important questions, as this “new” PGS is actively marketed to patients as “proven” and “established” to increase IVF success rates. In the late ‘90s,
Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometrium
Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometriu …
November 15, 2012 (New York, NY) – Direct perfusion of the endometrial cavity with granulocyte colony-stimulating factor (G-CSF) improves the thickness of the endometrial lining in IVF patients with too thin endometrium even after treatments, according to a new study just published online in the medical journal Human Reproduction(1). In the study, 21 women undergoing in vitro fertilization (IVF) cycles at the Center for Human Reproduction (CHR) in New York City
FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
October 23, 2012 (New York, NY) – A new study presented at the Annual Meeting of the American Society for Reproductive Medicine (ASRM) in San Diego, CA, offers further evidence that the fragile X mental retardation 1 gene (FMR1 gene) may play an important role in controlling women’s fertility life cycles. The study, conducted by researchers from the Center for Human Reproduction (CHR), a leading fertility center in New York
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Screening and Treatment
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Scree …
BRCA1/2 gene mutations, widely associated with breast and ovarian cancer risks in women, are, in principle, lethal to human embryos, according to new research conducted by three teams of researchers from the Center for Human Reproduction (CHR) in New York City, the Medical University Vienna in Vienna, Austria, and the Medical University Graz, Graz, Austria. BRCA1/2-positive embryos will only survive when also carrying a specific FMR1 gene genotype. In a paper

All 4 Releases


More Releases for CHR

Bifidobacterium Market Size | Industry Report, 2027|Chr Hansen, DSM, Yakult
LOS ANGELES, United States: The report is an all-inclusive research study of the global Bifidobacterium market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive analysis of the global Bifidobacterium market with the help of research methodologies such as PESTLE and Porter’s Five Forces analysis. They have provided accurate and reliable market data and useful recommendations to help
Compound Lipase Market Foreseen to Grow Exponentially by 2028 | DSM BioSolutions …
This detailed market study covers compound lipase market growth potentials which can assist the stake holders to understand key trends and prospects in compound lipase market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The
Probiotics Market In-Depth Industry Analysis 2025 Top Leading Players: Chr. Hans …
Probiotics Market report deals with the breakdown of global information by producers, application and product type while dissecting the market status, market share, market analysis, development rate, future demand trends, industry drivers, opportunities and challenges, sales channels, and wholesalers. The key factors driving the probiotics market are rising demand from functional food and dietary supplements industry and increasing health consciousness among consumers. Global probiotics market report also contains a precise
Compound Lipase Market Insights on Trends, Drivers and Opportunities by 2023 & k …
Compound Lipase Market Compound Lipase Market was valued at USD xx Million in 2017 and projected to reach USD xx Million by 2023 growing at a CAGR of 6.8% during the forecast period 2018 to 2023. Compound Lipase Market Overview: Lipase is a compound which plays crucial role in digestion process. It is a sub class of the esterase. The compound lipase is used in the applications of baking in the modern days.
Global Probiotics Market 2019 - DuPont (Danisco), Chr. Hansen, Lallemand, China- …
This new report by Eon Market Research, titled “Global Probiotics Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Probiotics industry at a global as well as regional and country level. Key facts analyzed in this report include the Probiotics market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Carotenoids Market – Sophisticated Performance 2025 | Farbest Brands, Chr. Han …
Global Carotenoids Market: Overview Carotenoids, a class of phytonutrients, are plant pigments due to which several fruits and vegetables acquire their bright shades of red, orange, and yellow. Several algae, bacteria, and plants contain these pigments. Acting as anti-oxidants, carotenoids possess cancer-fighting properties, suggests recent research. Carotenoids also have anti-inflammatory properties, improve the immune system, and are believed to aid in the prevention of cardiovascular diseases. Some of the fruits and